Found 10 matching trials
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms PHASE2 To explore the efficacy of SPD489, as adjunctive therapy to a stable dose o...
Show More Location
K&S Professional Research Services
Learn More & Join Trial
A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users PHASE1 This single-center study will be a single-dose, randomized, double-blind, p...
Show More Location
Vince and Associates Clinical Research, Inc.
Learn More & Join Trial
Attention & Memory Impairments in Menopausal Women PHASE4 The purpose of this study is to determine whether a medication called Vyvan...
Show More Location
Penn Center for Women's Behavioral Wellness
Learn More & Join Trial
Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression PHASE4 There have been reports that stimulants may be effective for bipolar depres...
Show More Location
Steward St. Elizabeth's Medical Center
Learn More & Join Trial
Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD PHASE4 There has been little research on the third area of impairment noted in the...
Show More Learn More & Join Trial
Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia PHASE3 The primary purpose of this study is to determine whether SPD489 40 mg, 100...
Show More Location
University Hills Clinical Research
Learn More & Join Trial
SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia PHASE3 To assess the safety and efficacy of SPD489 low-dose and high-dose treatmen...
Show More Location
Multiple Locations
Learn More & Join Trial
Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia PHASE3 The primary purpose of this study is to determine if the long-term use of S...
Show More Location
SP Research PLLC/Oklahoma Clinical Research Center
Learn More & Join Trial
SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia PHASE3 The primary purpose of this study is to determine whether SPD489 low dose r...
Show More Learn More & Join Trial
Real World Evidence of the Efficacy and Safety of FOQUEST PHASE4 This study is a four-month, phase IV, open-label study of ADHD symptomatolo...
Show More Location
Matheson Centre for Mental Health Research & Education, University of Calgary
Learn More & Join Trial